Overexpression of CXCR4 in primary tumor of patients with HER-2 negative breast cancer was predictive of a poor disease-free survival: A validation study

Annals of Surgical Oncology

Volumn 16, Issue 10, 2009, Pages 2711-2716

  Mizell, Jason ^a   Smith, Mark ^a   Li, Benjamin D L ^a,b   Ampil, Fred ^a   Chu, Quyen D ^a,b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; CXCR4 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE FREE SURVIVAL; FEMALE; FISHER EXACT TEST; GENE OVEREXPRESSION; HAZARD RATIO; HELA CELL; HUMAN; HUMAN CELL; IRRADIATION; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PREDICTION; PRIMARY TUMOR; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; VALIDATION STUDY; WESTERN BLOTTING; AGED; BREAST TUMOR; CANCER INVASION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HELA CELLS; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RECEPTORS, CXCR4; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 73349137335     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0551-0     Document Type: Article

References (10)

1. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50-6.
2. Proudfoot A. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol. 2002;2:106-15.
3. Holm N, Byrnes K, Li B, Turnage R, Abreo F, Mathis J, et al. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence. J Surg Res. 2007; 141:91-6.
4. Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L, Shim H. Silencing of CXCR4 blocks breast cancer metastasis. CancerRes. 2005;65:967-71.
5. Lapteva N, Yang A, Sanders D, Strube RW, Chen SY. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther. 2005;12:84-9.
6. Smith M, Luker K, Garbow J, Prior JL, Jackson E, Piwnica-Worms D, et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 2004;64:8604-12.
7. Holm N, Abreo F, Johnson LW, Li B, Chu QD. Elevated che-mokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC). Breast Cancer Res Treat. 2009;113:293-9.
8. Chu QD, Panu L, Holm N, Li B, Johnson LW, Zhang S. High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome. J Surg Res. DOI: 10.1016/j.jss.2008.09.020.
9. Kato M, Kitayama J, Kazama S, Nagawa H. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res. 2003;5:144-50.
10. Kang H, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast. 2005;14:360-7.